Key result
In a rat model of bupivacaine toxicity, central continuous infusion (80%) and peripheral bolus injections (73%) of lipid emulsion yielded higher survival than peripheral continuous infusion (20%).
Why the study?
Does the locus and mode of intravenous lipid emulsion delivery improve survival in rats with bupivacaine toxicity?
Does the locus and mode of intravenous lipid emulsion delivery improve survival in rats with bupivacaine toxicity?
No takes yet. Share an insight, caveat, or question.
Central continuous infusion or peripheral bolus injections of lipid emulsion appear more effective than peripheral continuous infusion for reversing bupivacaine-induced asystole in a rat model.
Zeballos et al. (2019) conducted an editorial in Local Anesthetic Systemic Toxicity (LAST). Intravenous lipid emulsions (ILE) was evaluated on Survival rates. In a rat model of bupivacaine toxicity, central continuous infusion (80%) and peripheral bolus injections (73%) of lipid emulsion yielded higher survival than peripheral continuous infusion (20%).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: